Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use BEVESPI AEROSPHERE safely and effectively. See full prescribing information for BEVESPI AEROSPHERE. BEVESPI AEROSPHERE® (glycopyrrolate and formoterol fumarate) inhalation aerosol, for oral inhalation useInitial U.S. Approval: 2016
Medication labelWhy this: Advisory · dailymed-prescription
BEVESPI AEROSPHERE is indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). Limitations of Use: BEVESPI AEROSPHERE is not indicated for the relief of acute bronchospasm or for the treatment of asthma [see Warnings and Precautions (5.1, 5.2)].
- generic_name
- glycopyrrolate and formoterol fumarate
- product_names
- Glycopyrrolate and formoterol fumarate
- ndc
- 0310-4600, 0310-4600-12, 0310-4600-28, 0310-4600-39
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en